Liaw YF - Search Results

1

Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: a case control study.

Chien RN, Sheen IS, Liaw YF. Chien RN, et al. Among authors: liaw yf. J Gastroenterol Hepatol. 1993 Nov-Dec;8(6):574-6. doi: 10.1111/j.1440-1746.1993.tb01655.x. J Gastroenterol Hepatol. 1993. PMID: 7506585

2

Etiology of sporadic acute viral hepatitis in Taiwan: the role of hepatitis C virus, hepatitis E virus and GB virus-C/hepatitis G virus in an endemic area of hepatitis A and B.

Chu CM, Lin SM, Hsieh SY, Yeh CT, Lin DY, Sheen IS, Liaw YF. Chu CM, et al. Among authors: liaw yf. J Med Virol. 1999 Jun;58(2):154-9. doi: 10.1002/(sici)1096-9071(199906)58:2<154::aid-jmv9>3.0.co;2-e. J Med Virol. 1999. PMID: 10335863

3

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.

Liaw YF, Chien RN, Yeh CT, Tsai SL, Chu CM. Liaw YF, et al. Hepatology. 1999 Aug;30(2):567-72. doi: 10.1002/hep.510300221. Hepatology. 1999. PMID: 10421670 Clinical Trial.

4

Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.

Chien RN, Liaw YF, Atkins M. Chien RN, et al. Among authors: liaw yf. Hepatology. 1999 Sep;30(3):770-4. doi: 10.1002/hep.510300313. Hepatology. 1999. PMID: 10462384 Clinical Trial.

5

Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: a prospective controlled study.

Huang MJ, Tsai SL, Huang BY, Sheen IS, Yeh CT, Liaw YF. Huang MJ, et al. Among authors: liaw yf. Clin Endocrinol (Oxf). 1999 Apr;50(4):503-9. doi: 10.1046/j.1365-2265.1999.00686.x. Clin Endocrinol (Oxf). 1999. PMID: 10468911

6

Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B.

Liaw YF, Chien RN. Liaw YF, et al. J Gastroenterol Hepatol. 1999 Aug;14(8):804-6. doi: 10.1046/j.1440-1746.1999.01960.x. J Gastroenterol Hepatol. 1999. PMID: 10482433

7

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis.

Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, Yeh CT, Chang KS, Huang SN, Kuo GC, Liaw YF. Tai DI, et al. Among authors: liaw yf. Hepatology. 2000 Mar;31(3):656-64. doi: 10.1002/hep.510310316. Hepatology. 2000. PMID: 10706556

8

Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant.

Yeh CT, Sheen IS, Chen TC, Hsieh SY, Chu CM, Liaw YF. Yeh CT, et al. Among authors: liaw yf. J Hepatol. 2000 May;32(5):829-36. doi: 10.1016/s0168-8278(00)80253-6. J Hepatol. 2000. PMID: 10845671 Clinical Trial.

9

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S, Lai CL. Liaw YF, et al. Gastroenterology. 2000 Jul;119(1):172-80. doi: 10.1053/gast.2000.8559. Gastroenterology. 2000. PMID: 10889166 Clinical Trial.

10

Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.

Liaw YF, Tsai SL, Chien RN, Yeh CT, Chu CM. Liaw YF, et al. Hepatology. 2000 Sep;32(3):604-9. doi: 10.1053/jhep.2000.9717. Hepatology. 2000. PMID: 10960456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

560 results

Search Page

Filters